The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGILE THERAPEUTICS INC | COM | 00847L100 | 3,370 | 3,510,189 | SH | SOLE | 3,510,189 | 0 | 0 | ||
LAZARD LTD | COM | G54050102 | 589 | 12,850 | SH | SOLE | 12,850 | 0 | 0 | ||
STANLEY BLACK & DECKER INC | COM | 854502101 | 543 | 3,100 | SH | SOLE | 3,100 | 0 | 0 | ||
NASDAQ INC | COM | 631103108 | 3,743,457 | 19,394,142 | SH | SOLE | 19,394,142 | 0 | 0 |